newsfilter
← Latest News
GlobeNewswire·

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting